Analysis of the proportion of CD4+ T, CD8+ T, and central memory T cells (CD44+ CD62L+) showed that SPNI-mediated photodynamic immunotherapy can be used as a vaccine for cancer to stimulate strong anti-tumor T cell immunity, which helps to inhibit local and surrounding tumor growth (Figure 14B). The gene discussed is CD44; the disease is neoplasm.